Address
Quaker BioVentures Inc
2929 Arch Street
Cira Centre
Philadelphia, PA 19104
United States
Phone
Website
VCID: 27817
Profile
Corporate information
Official name
Quaker BioVentures Inc
Investment activity status
Active investor
Team
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Neuronetics Inc |
United States | 1 May 2011 1 Oct 2009 |
Series E |
|
|
|
Celator Pharmaceuticals Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. |
United States | 1 Jul 2008 1 May 2005 1 Sep 2010 |
Series D Active |
|
|
|
TetraLogic Pharmaceuticals A leader in the discovery and development of small molecule drugs called Smac mimetics for the treatment of cancers. |
United States | 1 Aug 2010 1 Jun 2006 |
Series C Active |
|
|
|
TearScience Inc Developer of a diagnostic and treatment devices targeted at the root cause of the majority of dry eye cases. |
United States | 1 May 2010 | Series C Active |
|
|
|
Arginetix Inc Biopharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase. |
United States | 1 Oct 2008 | Seed |
|
|
|
Biolex Therapeutics Inc |
United States | 1 May 2007 1 Oct 2008 1 Sep 2005 |
Series D Active |
|
|
|
Tranzyme Pharma Drug discovery and development, focused on gastroenterology indications |
United States | 1 May 2005 1 Nov 2007 |
N/A |
|
|
|
Amicus Therapeutics Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
EKR Therapeutics Inc |
United States | N/A |
||
|
|
NuPathe Inc Developer of branded therapeutics for neurological and psychiatric disorders. |
United States | N/A |
||
|
|
TargetRx Inc Provider of insight to the pharmaceutical and biotech enterprises into the drivers of prescribing. |
United States | N/A |
||
|
|
BioLeap LLC |
United States | N/A |
||
|
|
Eximias Pharmaceutical Corp Developing late stage cancer therapeutics. |
United States | N/A |